Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease.
Patients with type 2 diabetes mellitus (DM) and those with impaired glucose tolerance are at increased risk for the development of cardiovascular disease. With an increasing global incidence and prevalence of type 2 DM, and with the 2003 lowering of the glucose threshold required for the diagnosis o...
主要な著者: | Bethel, M, Califf, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2007
|
類似資料
-
Treatment of diabetes mellitus: implications of the use of oral agents.
著者:: Rao, S, 等
出版事項: (1999) -
Lifestyle Modification in the Prevention of Type II Diabetes Mellitus
著者:: Muhammad Umair Khan
出版事項: (2012-03-01) -
Oral agent therapy in the treatment of type 2 diabetes.
著者:: Feinglos, M, 等
出版事項: (1999) -
The Role of Lifestyle Interventions in the Prevention and Treatment of Gestational Diabetes Mellitus
著者:: Hala Zakaria, 等
出版事項: (2023-02-01) -
The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents.
著者:: Dante S Harbuwono, 等
出版事項: (2020-01-01)